14 Feb 2014 07:00
Ultrasis plc
("Ultrasis" or the "Company")
Acquisition of Shares by a Director under Share Incentive Plan and Block Listing Six Monthly Update
Ultrasis, the provider of interactive health care services, today announces, as required by the AIM Rules, that John Smith, CEO, as a participant of the Company's Share Incentive Plan ("SIP"), has acquired the following Ordinary Shares ("Partnership Shares") and have been conditionally awarded the following Ordinary Shares ("Matching Shares"), under the terms of the SIP and at a price of 1.04p each (being the lower of the price at the start of the accumulation period and the price on the acquisition date as set out in the HMRC approved SIP rules):
No. of Partnership Shares | Purchase price | No. of Matching Shares | Purchase price | |
John Smith | 36,057 | 1.04p | 72,114 | 1.04p |
The SIP is open to all employees on the same terms where, for every Ordinary Share purchased by an employee, the Company will match it with two Matching Shares. The Matching Shares are released at the end of a three year holding period (subject to the SIP rules) and the maximum amount that may be invested in Partnership Shares in any tax year is £1,500 per employee. John Smith has each committed to invest the maximum of £125 per month.
Following this transaction, John Smith now holds the following Ordinary Shares, together with options over the same (including Matching Shares) and exercisable at various prices up to 1.35 pence, as follows:
No. of Ordinary Shares | No. of options | Percentage of existing share capital held | |
John Smith | 3,648,621 | 17,666,667 | 0.2% |
Block Listing Six Monthly Update
The Company provides the following update in accordance with Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements:
a | Name of company
| Ultrasis PLC |
b | Name of scheme
| Unapproved and EMI Share Option Schemes |
c | Period of return (from/ to)
| 02 May 2013 to 13 February 2014 |
d | Number and Class of Securities not issued at the start of the period under the scheme
| 151,100,000 (ordinary shares of 0.1 pence each) |
e | Number of securities issued under the scheme during the period
| Nil (ordinary shares of 0.1 pence each)
|
f | Balance under the scheme of securities not yet issued at the end of the period
| 151,100,000 (ordinary shares of 0.1 pence each) |
g | Number and class of securities originally admitted and the date of admission | 39,600,000 (ordinary shares of 0.1 pence each) Date of Grant of Listing - 09 November 2010
111,500,000 (ordinary shares of 0.1 pence each) Date of Grant of Listing - 31 July 2009 |
For all enquiries relating to Ultrasis please contact
Ultrasis plc | Tel: +44 (0) 20 7535 2050 |
Penelope Tembra, Finance Director | |
finnCap Limited | Tel: +44 (0) 20 7220 0500 |
Geoff Nash/Simon Hicks | |
Notes to Editors
Ultrasis is a healthcare company with core expertise in health, psychology, software development and programme management. We deliver a range of healthcare products to the consumer, the NHS, the corporate sector and other healthcare providers in the UK and Internationally. Ultrasis was the first company to offer computerised products based on Cognitive Behavioural Therapy (CBT) and interactive multimedia, and is still the world leader in this field.